Pharmaceuticals & Biologics

Visible Particles in Parenteral Drug Products: A Review of Current Safety Assessment Practice

Visible Particles in Parenteral Drug Products: A Review of Current Safety Assessment Practice Visible particles (VPs) in parenteral drug products…

2 years ago

The Role of Statistics in Clinical Trials: Safeguarding Patient Safety and Improving Healthcare Outcomes through Rigorous Evaluation of Medical Treat.

Introduction:  Clinical trials are essential for evaluating the safety and efficacy of new medical treatments. They provide a rigorous framework…

2 years ago

Why DQ, IQ, OQ, PQ Are Mandatory in Quality Assurance: Why It’s Essential and How to Handle It

Why DQ, IQ, OQ, PQ Are Mandatory in Quality Assurance: Why It’s Essential and How to Handle It? By :Dr.…

2 years ago

Cleaning Validation and Verification Reporting: A Mandatory QA Requirement

Cleaning Validation and Verification Reporting: A Mandatory QA Requirement By :Dr. Dhriti Tupe, GxP Expert ® Introduction In pharmaceutical manufacturing, ensuring…

2 years ago

Handling Elemental Impurities Risk Assessments in Pharmaceuticals

Handling Elemental Impurities Risk Assessments in Pharmaceuticals By :Dr. Dhriti Tupe, GxP Expert ® A Comprehensive Guide Elemental impurities in…

2 years ago

Leading Hidradenitis Suppurativa Treatments in the Market

Leading Hidradenitis Suppurativa Treatments in the Market Currently, some of the top medications for treating hidradenitis suppurativa (HS) include BIMZELX…

2 years ago

Exploring Pharmacokinetic (PK) Data and Strategies for Analysis

Some basics of Pharmacokinetics (PK) analysis: Pharmacokinetics refers to the study of how a drug is absorbed, distributed, metabolized, and eliminated…

2 years ago

Bristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer

Bristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer Bristol Myers Squibb (BMS) is set…

2 years ago

Keytruda’s Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care

Keytruda's Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care Merck's Keytruda (pembrolizumab) has achieved a significant milestone…

2 years ago

GSK Advances mRNA Flu Vaccine to Late-Stage Trials Following Positive Mid-Stage Results

GSK Advances mRNA Flu Vaccine to Late-Stage Trials Following Positive Mid-Stage Results British pharmaceutical giant GSK has announced promising results…

2 years ago